Gasdynamic Atomization for Medical Implant Coating Morphology Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for forming coatings on medical implants and tissue surfaces lack control over particle formation and deposition, leading to uneven distribution, reduced biocompatibility, and inefficient drug delivery due to excessive solvent residuals and poor morphology control.
Innovation Solution
A versatile spraying process and apparatus that atomizes a liquid composition into submicron droplets, allowing for precise control of coating morphology by adjusting the amount of submicron sized droplets and gas stream interactions, ensuring homogeneous coatings with improved adhesion and drug diffusion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional coating processes are used, then coating can be applied to medical implants, but the coating morphology is poorly controlled leading to uneven distribution and decreased biocompatibility
Solution Approach 1:
The patent applies parameter changes by precisely controlling atomization parameters (gas pressure, liquid flow rate, nozzle geometry) and deposition parameters (substrate temperature, distance from nozzle) to achieve controlled particle formation and uniform coating morphology in the nano-micrometer range, directly resolving the contradiction between manufacturing precision and biocompatibility
Solution Approach 2:
The patent replaces conventional mechanical coating methods with a gasdynamic atomization system where high-velocity gas streams break up liquid coatings into fine particles that deposit uniformly on substrates, achieving superior morphology control and biocompatibility through fluid dynamic control rather than mechanical application
2Manufacturing precision
If conventional atomization is used, then coating can be deposited, but particle size control is insufficient leading to non-homogeneous coatings
Solution Approach 1:
The patent employs parameter changes by systematically adjusting atomization pressure, liquid composition viscosity, nozzle orifice dimensions, and gas-to-liquid ratio to produce monodisperse particles with precise size control in the nano-micrometer range, ensuring homogeneous coating deposition
Solution Approach 2:
The patent implements feedback control by monitoring particle size distribution during atomization and adjusting operating parameters in real-time to maintain consistent particle dimensions and coating uniformity, preventing deviations in coating quality
3Ease of manufacture
If high solvent content is used in coating composition, then coating can be applied smoothly, but excessive solvent residuals remain decreasing therapeutic substance potency
Solution Approach 1:
The patent utilizes phase transitions by controlling the evaporation of volatile solvents during the atomization and deposition process, where the rapid transition from liquid to vapor phase eliminates excess solvent before coating formation, preventing solvent residuals while maintaining smooth coating application
Solution Approach 2:
The patent replaces thermal drying processes with gasdynamic atomization that inherently removes solvents through high-velocity gas flow and rapid evaporation during particle formation, achieving solvent elimination without compromising therapeutic substance integrity
4Quantity of substance
If conventional coating methods are used, then coating can be formed, but drug load and drug release are insufficiently controlled
Solution Approach 1:
The patent applies parameter changes by controlling liquid composition concentration, atomization rate, and deposition conditions to precisely regulate the amount of therapeutic substance incorporated into the coating (drug load) and the rate at which it releases, achieving dual control over quantity and release kinetics
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves reproducible, homogeneous coatings with enhanced biocompatibility and drug delivery efficiency, minimizing solvent residuals and optimizing surface features for improved adhesion and drug release.
Implementation Method 1
atomizing the liquid composition so that droplets having an initial median droplet size of less than four microns are produced
Implementation Method 2
a second conduit for flowing a first gas stream from a second inlet to a second orifice
Implementation Method 3
particles are formed from the non-volatile component of the liquid composition
Implementation Method 4
depositing the particles on the substrate to form a coating with a desired morphology
Data Source
AI summary
This invention relates to a method to produce reproducible and homogeneous coatings and to fine-tune the coating morphology. More particularly, the invention relates to a method and apparatus for controlling the particle formation and deposition process to form a biocompatible coating on a medical implant or a tissue.


